Osteoarthritis and bone mineral density: are strong bones bad for joints?

Sarah A Hardcastle, Paul Dieppe, Celia L Gregson, George Davey Smith, Jon H Tobias

Research output: Contribution to journalArticle (Academic Journal)peer-review


Osteoarthritis (OA) is a common and disabling joint disorder affecting millions of people worldwide. In OA, pathological changes are seen in all of the joint tissues including bone. Although both cross-sectional and longitudinal epidemiological studies have consistently demonstrated an association between higher bone mineral density (BMD) and OA, suggesting that increased BMD is a risk factor for OA, the mechanisms underlying this observation remain unclear. Recently, novel approaches to examining the BMD-OA relationship have included studying the disease in individuals with extreme high bone mass, and analyses searching for genetic variants associated with both BMD variation and OA, suggesting possible pleiotropic effects on bone mass and OA risk. These studies have yielded valuable insights into potentially relevant pathways that might one day be exploited therapeutically. Although animal models have suggested that drugs reducing bone turnover (antiresorptives) may retard OA progression, it remains to be seen whether this approach will prove to be useful in human OA. Identifying individuals with a phenotype of OA predominantly driven by increased bone formation could help improve the overall response to these treatments. This review aims to summarise current knowledge regarding the complex relationship between BMD and OA.

Original languageEnglish
Pages (from-to)624
JournalBoneKEy Reports
Publication statusPublished - 2015


Dive into the research topics of 'Osteoarthritis and bone mineral density: are strong bones bad for joints?'. Together they form a unique fingerprint.

Cite this